FDx Advisors’s HUTCHMED HCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-10,197
Closed -$193K 839
2022
Q1
$193K Sell
10,197
-206
-2% -$5.24K 0.01% 799
2021
Q4
$365K Sell
10,403
-653
-6% -$21.2K 0.01% 630
2021
Q3
$405K Sell
11,056
-113
-1% -$4.44K 0.01% 568
2021
Q2
$439K Sell
11,169
-222
-2% -$6.41K 0.01% 543
2021
Q1
$322K Buy
11,391
+228
+2% +$7.27K 0.01% 606
2020
Q4
$357K Buy
11,163
+110
+1% +$3.38K 0.01% 524
2020
Q3
$357K Buy
+11,053
New +$345K 0.02% 449

Other funds holding HCM

FDx Advisors's HCM Position: Q2 2022 in Review

FDx Advisors sold out of HUTCHMED (HCM) in Q2 2022, closing a stake of 10,197 shares — an estimated $193K sold.

FDx Advisors first reported a position in HCM in Q3 2020 and held it in 7 quarters. The position peaked at $439K in Q2 2021. 116 funds tracked by Wall St. Rank hold HCM as of Q2 2022.

  • FDx Advisors reported no remaining HUTCHMED position as of Q2 2022 after selling out during the quarter.
  • FDx Advisors sold 10,197 HUTCHMED shares in Q2 2022, an estimated $193K.
  • FDx Advisors first reported a position in HUTCHMED in Q3 2020 and held it in 7 quarters.
  • FDx Advisors's HUTCHMED position peaked at $439K in Q2 2021.
  • 116 funds tracked by Wall St. Rank held HUTCHMED as of Q2 2022.

Based on FDx Advisors's 13F filing for Q2 2022, filed 3 Aug 2022.